Treatment of Angelman syndrome using ASO targeting UBE3A-AS
Primary Investigator: S. Dindot
This program supported further exploration of various ASO candidates for paternal gene activation through antisense technology.
Primary Investigator: S. Dindot
This program supported further exploration of various ASO candidates for paternal gene activation through antisense technology.